Synthesis, structure and biological activity of cobalt(II) and copper(II) complexes of valine-derived schiff bases.

[1]  D. Hodgson.  The Structural and Magnetic Properties of First‐Row Transition‐Metal Dimers Containing Hydroxo, Substituted Hydroxo, and Halogen Bridges , 2007 .

[2]  D. Hadjipavlou-Litina,et al.  In vivo anticancer, anti-inflammatory, and toxicity studies of mixed-ligand Cu(II) complexes of dien and its Schiff dibases with heterocyclic aldehydes and 2-amino-2-thiazoline. Crystal structure of [Cu(dien)(Br)(2a-2tzn)](Br)(H(2)O). , 2005, Journal of inorganic biochemistry.

[3]  Mehmet Tümer,et al.  Cd(II) and Cu(II) complexes of polydentate Schiff base ligands: synthesis, characterization, properties and biological activity , 2005 .

[4]  M. Pfaller,et al.  Activities of Available and Investigational Antifungal Agents against Rhodotorula Species , 2005, Journal of Clinical Microbiology.

[5]  M. Pfaller,et al.  In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. , 2004, Diagnostic microbiology and infectious disease.

[6]  Jian-Zhong Wu,et al.  Synthesis and DNA interaction studies of a binuclear ruthenium(II) complex with 2,9-bis(2-imidazo[4,5-f][1,10]phenanthroline)-1,10-phenanthroline as bridging and intercalating ligand. , 2004, Journal of inorganic biochemistry.

[7]  A. Zaas,et al.  Risk of Fungemia Due to Rhodotorula and Antifungal Susceptibility Testing of Rhodotorula Isolates , 2003, Journal of Clinical Microbiology.

[8]  J. Cleary,et al.  Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States , 2003, Antimicrobial Agents and Chemotherapy.

[9]  M. Peruzzini,et al.  Synthesis, catalytic properties and biological activity of new water soluble ruthenium cyclopentadienyl PTA complexes [(C5R5)RuCl(PTA)2] (R = H, Me; PTA = 1,3,5-triaza-7-phosphaadamantane). , 2003, Chemical communications.

[10]  P. A. Lay,et al.  Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized , 2002 .

[11]  K. Natarajan,et al.  Antibacterial activity of ruthenium(II) carbonyl complexes containing tetradentate Schiff bases , 2002 .

[12]  E. Monte,et al.  Thiourea derivatives and their nickel(II) and platinum(II) complexes: antifungal activity. , 2002, Journal of inorganic biochemistry.

[13]  M. Ward,et al.  Complexes of ruthenium(III) and chromium(III) with a new tetradentate N2O2-donor ligand: crystal structures, redox properties and spectroelectrochemistry , 2001 .

[14]  M. Nath,et al.  Organotin(IV) complexes of amino acids and peptides , 2001 .

[15]  C. Raptopoulou,et al.  Copper(II) complexes with phenoxyalkanoic acids and nitrogen donor heterocyclic ligands: structure and bioactivity. , 2001, Journal of inorganic biochemistry.

[16]  O. Mohammed,et al.  Synthesis, Spectral and Thermal Studies on Cobalt(II), Copper(II), Nickel(II) and Zinc(II) Chelates with p-tolylsalicylaldimine and Some Amino Acids , 2000 .

[17]  C. Raptopoulou,et al.  Structurally diverse copper(II)-carboxylato complexes: neutral and ionic mononuclear structures and a novel binuclear structure. , 2000, Inorganic chemistry.

[18]  Maneesh Sharma,et al.  Studies on Coordination Compounds of Organotin(IV) with Schiff Bases of Amino Acids , 2000 .

[19]  F. J. Luque,et al.  Theoretical Evaluation of Solvent Effects on the Conformational and Tautomeric Equilibria of 2-(2'-Hydroxyphenyl)benzimidazole and on Its Absorption and Fluorescence Spectra , 1999 .

[20]  M. Gupta,et al.  COORDINATION BEHAVIOUR OF BIOLOGICALLY ACTIVE SCHIFF BASES OF AMINO ACIDS TOWARDS STANNOUS ION , 1999 .

[21]  P. Bindu,et al.  Epr, cyclic voltammetric and biological activities of copper(II) complexes of salicylaldehyde N(4)-substituted thiosemicarbazone and heterocyclic bases , 1998 .

[22]  R. Pinner,et al.  The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  K. Nakajima,et al.  Photosubstitution reactivity, crystal structures, and electrochemistry of ruthenium(II) (III) complexes containing tetradentate (O2N2, S2N2, and P2N2) Schiff base ligands , 1998 .

[24]  S. García‐Granda,et al.  Cinoxacin complexes with divalent metal ions. Spectroscopic characterization. Crystal structure of a new dinuclear Cd(II) complex having two chelate-bridging carboxylate groups. Antibacterial studies. , 1998, Journal of inorganic biochemistry.

[25]  L. Brammer,et al.  Synthesis, characterization, and catalytic behavior of ruthenium(II) Schiff base complexes , 1997 .

[26]  A. Ramadan.  Structural and biological aspects of copper (II) complexes with 2-methyl-3-amino-(3H)-quinazolin-4-one. , 1997, Journal of inorganic biochemistry.

[27]  A. Ghaffar,et al.  Structural and Biological Behaviour of Co(II), Cu(II) and Ni(II) Metal Complexes of Some Amino Acid Derived Schiff-Bases , 1997, Metal-Based Drugs.

[28]  S. Zanetti,et al.  An electron spin resonance study and antimicrobial activity of copper(II)-phenanthroline complexes. , 1996, Journal of inorganic biochemistry.

[29]  D. Majumdar,et al.  Excited-State Intramolecular Proton Transfer in 2-(2-Hydroxyphenyl)benzimidazole and -benzoxazole: Effect of Rotamerism and Hydrogen Bonding , 1994 .

[30]  Roberto Sastre,et al.  Proton-transfer lasing from solid organic matrices , 1991 .

[31]  F. Kanzawa,et al.  Evaluation of the activity of some water‐soluble ferrocene and ferricenium compounds against carcinoma of the lung by the human tumor clonogenic assay , 1990 .

[32]  J. Sorenson,et al.  Copper complexes offer a physiological approach to treatment of chronic diseases. , 1989, Progress in medicinal chemistry.

[33]  Y. Muto,et al.  Factors affecting the magnetic properties of dimeric copper(II) complexes , 1988 .

[34]  S. Yamauchi,et al.  Fluorescence studies of the intramolecularly hydrogen-bonded molecules o-hydroxyacetophenone and salicylamide and related molecules , 1986 .

[35]  G. Brewer,et al.  Copper(II) and nickel(II) complexes of unsymmetrical tetradentate Schiff base ligands , 1985 .

[36]  M. Melnik.  Study of the relation between the structural data and magnetic interaction in oxo-bridged binuclear copper(II) compounds , 1982 .

[37]  K. Murray,et al.  Ruthenium complexes with a tetradentate salicylaldimine Schiff base , 1978 .

[38]  P. A. Vigato,et al.  Transition metal complexes with binucleating ligands , 1977 .

[39]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .

[40]  J. Kovacic.  The CN stretching frequency in the infrared spectra of Schiff's base complexes—I. Copper complexes of salicylidene anilines , 1967 .

[41]  E. Mayhew,et al.  Inhibition of Landschütz Ascites Tumour Growth by Metal Chelates Derived from 3,4,7,8-Tetramethyl-1,10-phenanthroline , 1965, British Journal of Cancer.

[42]  A. Martell,et al.  Inner Complex Chelates. I. Analogs of Bisacetylacetoneethylenediimine and its Metal Chelates1,2 , 1955 .